{"id":"W2591951146","doi":"10.1200/jco.2012.30.15_suppl.2572","title":"Does the addition of molecular targeted therapy to standard treatments lead to better or worse outcomes overall? A systematic review of EGFR-targeted therapies used in combination with standard treatments.","year":2012,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Statistics Canada; University of Toronto","funders":"","keywords":"Medicine; Oncology; Internal medicine; Erlotinib; Cetuximab; Targeted therapy; Progression-free survival; Rash; Lapatinib; Combination therapy; Pemetrexed; Gefitinib; Cancer; Trastuzumab; Breast cancer; Chemotherapy; Colorectal cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008744959,0.001168963,0.009845328,0.007649891,0.0004154736,0.002160408,0.001452896,0.001243268,0.003822168],"category_scores_gemma":[0.02776499,0.000912017,0.01081235,0.008221501,0.0007402453,0.001823747,0.001091462,0.0009597387,0.0003260324],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003103746,"about_ca_system_score_gemma":0.006173934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0051198,"about_ca_topic_score_gemma":0.0177237,"domain_scores_codex":[0.9921761,0.002975078,0.003268333,0.0005120508,0.0008957457,0.0001727022],"domain_scores_gemma":[0.9781537,0.01453423,0.005248046,0.0003249275,0.001515224,0.0002237619],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0006758554,0.00001258454,0.0007680975,0.9440862,0.03376063,0.00006367976,0.00009899543,0.00007941241,0.0002069337,0.0001017735,0.0007661133,0.01937966],"study_design_scores_gemma":[0.001293742,0.000795425,0.006352979,0.6407773,0.3360987,0.0003523011,0.0002241271,0.0001235949,0.0003072348,0.000279774,0.01334821,0.00004655006],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001945231,0.9966798,0.000131885,0.000190873,0.0001034992,0.0002717531,0.000450805,0.000007218615,0.0002190675],"genre_scores_gemma":[0.03210228,0.9651995,0.0007408261,0.00060634,0.0001134784,0.0006760706,0.0004023657,0.000008703884,0.0001504073],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009845328,"threshold_uncertainty_score":0.04624832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0988626422243408,"score_gpt":0.4955390530168683,"score_spread":0.3966764107925275,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}